EC
HALO icon

Elequin Capital’s Halozyme HALO Stock Holding History

Elequin Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-165
Closed -$10.7K – 792
2026
Q1 		$10.7K Sell
165
-349
-68% -$24.6K ﹤0.01% 317
2025
Q4 		$34.6K Buy
+514
New +$34.6K ﹤0.01% 161
2025
Q1 		– Sell
-402
Closed -$19.2K – 457
2024
Q4 		$19.2K Buy
402
+25
+7% +$1.28K ﹤0.01% 264
2024
Q3 		$21.6K Buy
+377
New +$21.6K ﹤0.01% 139
2024
Q2 		– Sell
-374
Closed -$15.2K – 257
2024
Q1 		$15.2K Buy
+374
New +$14K ﹤0.01% 65
2023
Q3 		– Sell
-190
Closed -$6.85K – 492
2023
Q2 		$6.85K Buy
+190
New +$6.48K ﹤0.01% 338
2022
Q4 		– Sell
-468
Closed -$19K – 665
2022
Q3 		$19K Buy
468
+153
+49% +$6.76K 0.01% 162
2022
Q2 		$14K Buy
315
+89
+39% +$3.85K ﹤0.01% 212
2022
Q1 		$9K Buy
+226
New +$8.05K ﹤0.01% 170

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Elequin Capital's HALO Position: Q2 2026 in Review

Elequin Capital sold out of Halozyme (HALO) in Q2 2026, closing a stake of 165 shares — an estimated $10.7K sold.

Elequin Capital first reported a position in HALO in Q1 2022 and held it in 9 quarters. The position peaked at $34.6K in Q4 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Elequin Capital reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Elequin Capital sold 165 Halozyme shares in Q2 2026, an estimated $10.7K.
  • Elequin Capital first reported a position in Halozyme in Q1 2022 and held it in 9 quarters.
  • Elequin Capital's Halozyme position peaked at $34.6K in Q4 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.